Bo Zhao

5.8k total citations
99 papers, 3.8k citations indexed

About

Bo Zhao is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Bo Zhao has authored 99 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Oncology, 35 papers in Molecular Biology and 35 papers in Pathology and Forensic Medicine. Recurrent topics in Bo Zhao's work include Viral-associated cancers and disorders (50 papers), Lymphoma Diagnosis and Treatment (35 papers) and Immune Cell Function and Interaction (21 papers). Bo Zhao is often cited by papers focused on Viral-associated cancers and disorders (50 papers), Lymphoma Diagnosis and Treatment (35 papers) and Immune Cell Function and Interaction (21 papers). Bo Zhao collaborates with scholars based in United States, China and Japan. Bo Zhao's co-authors include Elliott Kieff, Eric Johannsen, Benjamin E. Gewurz, Clare E. Sample, Sizun Jiang, Hufeng Zhou, Ellen Cahir-McFarland, James Zou, Seiji Maruo and Jon C. Aster and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Bo Zhao

96 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo Zhao United States 37 2.2k 1.5k 976 962 821 99 3.8k
Eric Johannsen United States 36 2.7k 1.3× 1.1k 0.7× 1.2k 1.2× 996 1.0× 1.3k 1.5× 66 4.0k
Takayuki Murata Japan 34 1.7k 0.8× 1.5k 1.0× 466 0.5× 788 0.8× 1.7k 2.0× 147 4.2k
Martin J. Allday United Kingdom 45 4.2k 1.9× 1.9k 1.2× 1.6k 1.6× 1.0k 1.1× 1.4k 1.7× 73 5.5k
David Reisman United States 37 2.5k 1.1× 3.8k 2.5× 1.6k 1.7× 634 0.7× 1.0k 1.2× 93 5.9k
Évelyne Manet France 30 1.8k 0.9× 788 0.5× 633 0.6× 554 0.6× 1.0k 1.2× 61 2.7k
Dagmar Pich Germany 21 1.5k 0.7× 679 0.4× 468 0.5× 563 0.6× 935 1.1× 29 2.3k
Päivi M. Ojala Finland 30 1.4k 0.7× 1.4k 0.9× 292 0.3× 315 0.3× 756 0.9× 60 2.8k
Henri Gruffat France 33 1.7k 0.8× 693 0.5× 543 0.6× 535 0.6× 1.0k 1.3× 67 2.6k
Kinuko Mitani Japan 41 1.1k 0.5× 3.8k 2.5× 429 0.4× 863 0.9× 314 0.4× 202 6.3k
Diana C. Hargreaves United States 19 827 0.4× 3.1k 2.0× 793 0.8× 2.2k 2.3× 271 0.3× 30 5.1k

Countries citing papers authored by Bo Zhao

Since Specialization
Citations

This map shows the geographic impact of Bo Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Zhao more than expected).

Fields of papers citing papers by Bo Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Zhao. The network helps show where Bo Zhao may publish in the future.

Co-authorship network of co-authors of Bo Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Zhao. A scholar is included among the top collaborators of Bo Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Zhao. Bo Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qi, Teng, Yujie Hu, Bo Zhao, et al.. (2024). Glioma-associated oncogene homolog 1 in breast invasive carcinoma: a comprehensive bioinformatic analysis and experimental validation. Frontiers in Cell and Developmental Biology. 12. 1478478–1478478.
2.
Wang, Chong & Bo Zhao. (2023). Epstein‐Barr virus and host cell 3D genome organization. Journal of Medical Virology. 95(11). e29234–e29234. 1 indexed citations
3.
Liu, Shangxin, Chong Wang, Gaurab Roy, et al.. (2023). Super-enhancer driven SOX2 promotes tumor formation by chromatin re-organization in nasopharyngeal carcinoma. EBioMedicine. 98. 104870–104870. 11 indexed citations
4.
Zhao, Bo, et al.. (2023). Efficacy of supramalleolar osteotomy in the treatment of traumatic ankle joint varus deformity in adolescents. Journal of Orthopaedic Surgery and Research. 18(1). 749–749.
5.
6.
Dakic, Aleksandra, Megan E. Spurgeon, Bhaskar Kallakury, et al.. (2022). AIB1 is a novel target of the high‐risk HPV E6 protein and a biomarker of cervical cancer progression. Journal of Medical Virology. 94(8). 3962–3977. 7 indexed citations
7.
Liu, Xiang, Bo Zhao, Timothy I. Shaw, et al.. (2022). Summarizing internal dynamics boosts differential analysis and functional interpretation of super enhancers. Nucleic Acids Research. 50(6). 3115–3127. 5 indexed citations
8.
Hu, Shan, et al.. (2022). Knockdown of hnRNPA1 Promotes NSCLC Metastasis and EMT by Regulating Alternative Splicing of LAS1L exon 9. Frontiers in Oncology. 12. 837248–837248. 9 indexed citations
9.
Liang, Jin, Chong Wang, Stephanie Pei Tung Yiu, et al.. (2021). Epstein-Barr Virus Induced Cytidine Metabolism Roles in Transformed B-Cell Growth and Survival. mBio. 12(4). e0153021–e0153021. 24 indexed citations
10.
Wu, Chunyan, Kunhua Wang, Bo Zhao, et al.. (2021). Metagenomic profiling reveals dominance of gram‐positive bacteria in the gut microbiome shifts associated with immunoglobulin A vasculitis (Henoch–Schönlein Purpura). Clinical & Translational Immunology. 10(10). e1342–e1342. 5 indexed citations
11.
12.
Wang, Chong, Luyao Zhang, Liang‐Ru Ke, et al.. (2020). Primary effusion lymphoma enhancer connectome links super-enhancers to dependency factors. Nature Communications. 11(1). 6318–6318. 24 indexed citations
13.
Guo, Rui, Yuchen Zhang, Mingxiang Teng, et al.. (2020). DNA methylation enzymes and PRC1 restrict B-cell Epstein–Barr virus oncoprotein expression. Nature Microbiology. 5(8). 1051–1063. 42 indexed citations
14.
Tian, Fu‐Ying, Chuanbo Xie, Bo Zhao, et al.. (2018). Placental surface area mediates the association between FGFR2 methylation in placenta and full-term low birth weight in girls. Clinical Epigenetics. 10(1). 39–39. 11 indexed citations
15.
Ma, Yijie, Michael J. Walsh, Katharina Bernhardt, et al.. (2017). CRISPR/Cas9 Screens Reveal Epstein-Barr Virus-Transformed B Cell Host Dependency Factors. Cell Host & Microbe. 21(5). 580–591.e7. 104 indexed citations
16.
Hunter, Jill V., Jacqueline Butterworth, Bo Zhao, et al.. (2015). The NF-κB subunit c-Rel regulates Bach2 tumour suppressor expression in B-cell lymphoma. Oncogene. 35(26). 3476–3484. 28 indexed citations
17.
Zhao, Bo, Nitin Yerram, Tianming Gao, Robert Dreicer, & Eric A. Klein. (2015). Long-term survival of patients with locally advanced prostate cancer managed with neoadjuvant docetaxel and radical prostatectomy. Urologic Oncology Seminars and Original Investigations. 33(4). 164.e19–164.e23. 16 indexed citations
18.
Zhou, Hufeng, Sizun Jiang, Katharina Bernhardt, et al.. (2015). Epstein-Barr Virus Oncoprotein Super-enhancers Control B Cell Growth. Cell Host & Microbe. 17(2). 205–216. 136 indexed citations
19.
Zhao, Bo, et al.. (2011). EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding. Proceedings of the National Academy of Sciences. 108(19). 7808–7813. 34 indexed citations
20.
Das, Sanjeev, Lakshmi Raj, Bo Zhao, et al.. (2007). Hzf Determines Cell Survival upon Genotoxic Stress by Modulating p53 Transactivation. Cell. 130(4). 624–637. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric Johannsen Breakdown of academic impact, for papers by Takayuki Murata Breakdown of academic impact, for papers by Martin J. Allday Breakdown of academic impact, for papers by David Reisman Breakdown of academic impact, for papers by Évelyne Manet Breakdown of academic impact, for papers by Dagmar Pich Breakdown of academic impact, for papers by Päivi M. Ojala Breakdown of academic impact, for papers by Henri Gruffat Breakdown of academic impact, for papers by Kinuko Mitani Breakdown of academic impact, for papers by Diana C. Hargreaves
Rankless by CCL
2026